Awakn Life Sciences Corp. operates as a biotechnology company. engages in clinical operations; researching, developing, and delivering psychedelic medicine to better treat Addiction. The firm develops next generation of psychedelic drugs, therapies, and enabling technologies to treat Addiction. The company was founded by Anthony Tennyson, Jonathan Held, Dr. Benjamin Sessa and George Scorsis in 2020 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company